Ophthalmology Innovation: Unmet Needs Fuel Market Growth
Summary of the Ophthalmology Market Overview by Kristen Ingenito
Hear’s a summary of the key takeaways from Kristen Ingenito’s presentation, as reported in the article:
Current Market State:
* Largest Segment: Retina pharmaceuticals is the largest segment within ophthalmology, despite being the slowest growing. This slow growth is notable as it’s coming from a vrey large base.
* Overall Market: the total addressable market is stable and expected to remain so for the next 5 years.
* Growth Leader: Implantables are currently the second largest segment but have the highest projected growth rate over the next 5 years.
Growth Drivers:
* New technology releases
* Strategic partnerships
* Patient population growth
* Increased access to care
Challenges & concerns:
* Payer Power: Influence from Medicare and private insurance could impact consumer confidence.
* Pricing Pressures: Pharmaceutical pricing is a concern.
* Regulatory Uncertainty: Changes in regulations could create challenges.
* Access to Care: Threats to access to care could hinder growth.
* Existing Problems: Ingenito notes thes challenges aren’t new to the field, offering a sense of preparedness.
opportunities & Innovations:
* Digital Tools: “Digital twins” and other digital tools are seen as a major possibility (“the grate multiplier”) to improve outcomes, patient flow, and reduce administrative burden. Strategic partnerships are key to faster implementation.
* unmet Needs: Innovation thrives where there are large unmet needs.
Event Information:
* the 2026 Eyecelerator meetings will be held before the ARVO and AAO meetings in Denver and New Orleans, respectively.
Source:
* The information is based on a presentation by Kristen Harmon Ingenito at the Eyecelerator@AAO meeting in Orlando on October 16, 2025.